CCND1 and breast carcinoma: Taken together, our data therefore reveal a new mechanism by which calcineurin inhibits cyclin D1 degradation by dephosphorylation of the T286 residue, facilitating cell cycle progression and robust cell growth in invasive breast cancer cells.